These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34674311)

  • 21. Luma is not essential for murine cardiac development and function.
    Stroud MJ; Fang X; Zhang J; Guimarães-Camboa N; Veevers J; Dalton ND; Gu Y; Bradford WH; Peterson KL; Evans SM; Gerace L; Chen J
    Cardiovasc Res; 2018 Mar; 114(3):378-388. PubMed ID: 29040414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy.
    Christensen AH; Andersen CB; Tybjaerg-Hansen A; Haunso S; Svendsen JH
    Clin Genet; 2011 Sep; 80(3):256-64. PubMed ID: 21214875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac MRI and Clinical Outcomes in
    Matos J; Helle E; Care M; Moayedi Y; Gollob MH; Thavendiranathan P; Spears D; Hanneman K
    Radiol Cardiothorac Imaging; 2023 Dec; 5(6):e230155. PubMed ID: 38166344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43.
    Hodgkinson KA; Connors SP; Merner N; Haywood A; Young TL; McKenna WJ; Gallagher B; Curtis F; Bassett AS; Parfrey PS
    Clin Genet; 2013 Apr; 83(4):321-31. PubMed ID: 22725725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations.
    AbdelWahab A; Gardner M; Parkash R; Gray C; Sapp J
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):90-97. PubMed ID: 28960618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype-phenotype Correlation and Pathophysiology.
    Fan X; Yang G; Duru F; Grilli M; Akin I; Zhou X; Saguner AM; Ei-Battrawy I
    Stem Cell Rev Rep; 2023 Nov; 19(8):2683-2708. PubMed ID: 37731079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    Chelko SP; Asimaki A; Lowenthal J; Bueno-Beti C; Bedja D; Scalco A; Amat-Alarcon N; Andersen P; Judge DP; Tung L; Saffitz JE
    Circulation; 2019 Oct; 140(18):1491-1505. PubMed ID: 31533459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
    Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
    Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy.
    Rajkumar R; Sembrat JC; McDonough B; Seidman CE; Ahmad F
    BMC Med Genet; 2012 Mar; 13():21. PubMed ID: 22458570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy.
    Boogerd CJ; Lacraz GPA; Vértesy Á; van Kampen SJ; Perini I; de Ruiter H; Versteeg D; Brodehl A; van der Kraak P; Giacca M; de Jonge N; Junker JP; van Oudenaarden A; Vink A; van Rooij E
    Cardiovasc Res; 2023 Mar; 119(2):477-491. PubMed ID: 35576477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.
    Bermúdez-Jiménez FJ; Carriel V; Brodehl A; Alaminos M; Campos A; Schirmer I; Milting H; Abril BÁ; Álvarez M; López-Fernández S; García-Giustiniani D; Monserrat L; Tercedor L; Jiménez-Jáimez J
    Circulation; 2018 Apr; 137(15):1595-1610. PubMed ID: 29212896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
    Cheedipudi SM; Hu J; Fan S; Yuan P; Karmouch J; Czernuszewicz G; Robertson MJ; Coarfa C; Hong K; Yao Y; Campbell H; Wehrens X; Gurha P; Marian AJ
    Cardiovasc Res; 2020 May; 116(6):1199-1213. PubMed ID: 31350552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TMEM43 Protects against Sepsis-Induced Cardiac Injury via Inhibiting Ferroptosis in Mice.
    Chen Z; Cao Z; Gui F; Zhang M; Wu X; Peng H; Yu B; Li W; Ai F; Zhang J
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene.
    Khudiakov A; Zaytseva A; Perepelina K; Smolina N; Pervunina T; Vasichkina E; Karpushev A; Tomilin A; Malashicheva A; Kostareva A
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165915. PubMed ID: 32768677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A homozygous DSC2 deletion associated with arrhythmogenic cardiomyopathy is caused by uniparental isodisomy.
    Brodehl A; Weiss J; Debus JD; Stanasiuk C; Klauke B; Deutsch MA; Fox H; Bax J; Ebbinghaus H; Gärtner A; Tiesmeier J; Laser T; Peterschröder A; Gerull B; Gummert J; Paluszkiewicz L; Milting H
    J Mol Cell Cardiol; 2020 Apr; 141():17-29. PubMed ID: 32201174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The homozygous variant c.245G > A/p.G82D in PNPLA2 is associated with arrhythmogenic cardiomyopathy phenotypic manifestations.
    Rao M; Guo G; Li M; Chen S; Chen K; Chen X; Song J; Hu S
    Clin Genet; 2019 Dec; 96(6):532-540. PubMed ID: 31525260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a CRISPR/Cas9-edited Plakoglobin (JUP) knock-out (JMUi001-A-4) iPSC line to model the cardiac phenotype of arrhythmogenic cardiomyopathy.
    Walz K; Janz A; Klopocki E; Gerull B
    Stem Cell Res; 2023 Dec; 73():103240. PubMed ID: 37995437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'It had to be done': genetic testing decisions for arrhythmogenic right ventricular cardiomyopathy.
    Etchegary H; Pullman D; Simmonds C; Young TL; Hodgkinson K
    Clin Genet; 2015 Oct; 88(4):344-51. PubMed ID: 25263618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
    Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
    Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.